Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2234-2753
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development ; volume:30 ; number:1 ; day:30 ; month:12 ; year:2014 ; pages:1-5 ; date:3.2014
Toxicological research ; 30, Heft 1 (30.12.2014), 1-5, 3.2014
- Urheber
-
Jung, Joohee
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.5487/TR.2014.30.1.001
- URN
-
urn:nbn:de:101:1-2021090420150088069339
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jung, Joohee
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cannabinoids as anticancer drugs: current status of preclinical research
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
Relevance of tumor models for anticancer drug development
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
New anticancer drugs
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
Cannabinoids as anticancer drugs: current status of preclinical research
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
Relevance of tumor models for anticancer drug development
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
New anticancer drugs
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
Cannabinoids as anticancer drugs: current status of preclinical research
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
Relevance of tumor models for anticancer drug development
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
New anticancer drugs
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients